Luxembourg’s Catalpa Ventures Raises €30M To Invest In Early-Stage HealthTech Startups

The fund has secured commitments from entrepreneurs, family offices, and industry leaders, targeting a final close by Q1 2027. Catalpa Ventures will invest in early-stage HealthTech startups across Europe, focusing on pre-seed and seed rounds, with plans for 15–20 investments over the next four years.

The fund’s launch comes amid growing pressures on Europe’s healthcare systems, including overstretched hospitals, medical staff shortages, rising costs, and an ageing population with multiple chronic conditions. The World Health Organization forecasts a shortfall of 4 million healthcare professionals by 2030. With healthcare expenditure averaging 10% of GDP and growing faster than the economy, sustainability is under strain.

Read Also - Algori Secures €3.6M To Expand Its AI-Powered Shopper Insights Platform Worldwide

Catalpa Health Fund I will back scalable, evidence-based solutions that strengthen clinical capacity and improve patient outcomes, aiming to impact at least 100 million people. The fund prioritizes European founders and technologies in disease prevention, healthcare professional support, and workflow or administrative efficiency, with investment sizes from €300k to €1.5 million and follow-on capacity for high-performing startups.

The fund reinforces Luxembourg’s emergence as a hub for healthcare innovation. Its founding team combines scientific, medical, entrepreneurial, and investment expertise, including Univ Prof Dr med Silke Sperling, Dr Thomas Goergen, Willibrord Ehses, and Dr Christian Goergen, enabling rigorous clinical due diligence and hands-on founder support.

“We are building a platform for bold innovation and real impact, backing tomorrow’s HealthTech leaders to transform care for millions,” said Dr Thomas Goergen, Partner at Catalpa Ventures.

“As evidence-based solutions converge with AI at unprecedented speed, a highly compelling opportunity emerges that the Catalpa Health Fund is uniquely positioned to capture,” added Prof Dr med Silke Sperling, Partner at Catalpa Ventures.

The Catalpa Health Fund I has made its first investment in Noah Labs, a startup developing a certified, reimbursable telemedicine platform for managing heart failure. Using advanced voice analytics to support earlier detection and improved patient care Noah Labs aims to reduce avoidable hospitalizations and set new benchmarks in personalized healthcare.